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A bstract:
Studies have been done on the decay rate o f messenger RNA (mRNA), including
the decay rate o f EGF-R mRNA. Several factors in the 3 ’ untranslated region (UTR) have
been suspected to affect the mRNA decay rate. However, no experiments have been done
to determine exactly what portion o f the 3’ UTR controls the decay rate. In order to
study the effects o f segments o f 3’ UTR, it is necessary to start with EGF-R and complete
3 ’ UTR. The focus o f this cloning procedure is to produce the EGF-R cDNA with
complete 3* UTR.
Copy DNA (cDNA) is single stranded DNA that is complementary to an RNA,
synthesized by the enzyme reverse transcriptase (in vitro). The cDNA contains only the
exons o f the gene. The EGF-R cDNA refers to the EGF-R cDNA and approximately 150
base pairs (bp) o f the 3’ untranslated region (UTR). The 3’ UTR is the region that
extends from the stop codon (termination o f protein synthesis) to the start o f the poly A
tail.
In this experiment, the EGF-R cDNA and entire 3’ UTR are first isolated. The
150 bp o f 3* UTR on the EGF-R cDNA is removed. The EGF-R cDNA (without the 150
bp o f 3* UTR) and the entire 3* UTR are then ligated together, and inserted into a vector
(i.e. plasmid). This hybrid plasmid will be inserted into a cell line by a process called
transfection. The stable transfection process results in cells that have incorporated the
EGF-R cDNA (with complete 3* UTR) into the cell's genome. This allows multiple
copies o f the gene to be made. The cells are lysed, and the DNA can be isolated for study.
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Introduction
This experiment utilizes recombinant DNA technology. In the experiment, a
vector, and insert are combined. A vector is a circular piece o f DNA found in bacteria. It
replicates independent o f the bacterial genome. Each time the plasmid replicates, the
desired gene replicates. The vector used in this cloning procedure contains a gene that
makes it resistant to the antibiotic ampicillian. This is referred to as the amp gene. This
gene allows the plasmid to be selected. This is accomplished by adding ampicillian to all
growth mediums. In this manner, only the bacteria with the amp gene (the desired
plasmid) will grow.
In this cloning procedure, there are two inserts, the EGF-R cDNA and the
complete 3 ’ UTR. It is important that both pieces are inserted into the correct order and
direction. Each piece o f DNA has a 5* and 3’ end. When RNA is produced, the enzyme
that produces the RNA (RNA polymerase) reads 5* to 3*. By convention, a strand DNA
is always written 5’ to 3’ (Fig. 1).
Fig. 1 Single Stranded DNA
5’ end -------------------------- 3’ end
Due to the method o f reading by polymerases, it is essential that the EGF-R cDNA
be upstream (toward the 5’ end) to the 3’ UTR. The 3* UTR must be directly 3’ to the
EGF-R cDNA. Also, both the EGF-R cDNA and 3* UTR must be put in the correct
orientation (Fig. 2).
Fig. 2 Correct Insert and Plasmid Orientations
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The cloning strategy entails cutting the DNA at specified points, and putting the
insert in the correct order. DNA is cut using restriction digests. Bacteria produce
different enzymes that cut DNA in different places. This is to protect the bacteria against
foreign DNA from entering its genome. Restriction enzymes recognize specific sequences
on the DNA and cut at that spot. Commercial plasmids have a multiple cloning site
(MCS). In this site, unique restriction sites are found. It is important to find a restriction
site that only cuts the plasmid one time. This will linearize the plasmid. It is also
important that the restriction site not be located in an important gene o f the plasmid, such
as the amp gene. This would not allow the bacteria with the plasmid to be selected.
When selecting restriction sites, it is important to choose a sites that produces
complementary sticky ends. For example, the 3* sticky end o f the linearized plasmid must
be complementary to the 5* end o f the EGF-R cDNA, and so forth (Fig. 3).

Fig. 3 Correct Plasmid and Inset Overlaps
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Results/Discussion
The EGF-R cDNA is present in the BSEGF-R vector. From this vector, the
EGF-R cDNA is isolated and cloned into the CMV (pcDNA3) vector. When the EGF-R
cDNA is cut out o f the BSEGF-R vector, all but a 150 bp fragment o f the 3’ UTR is
removed. The 150 bp fragment o f the 3’ UTR must be removed. The entire 3’ U TR will
then be to the EGF-R cDNA. The clonal plasmid will consist o f the CMV vector, the
EGF-R cDNA, and the entire 3* UTR.
Cloning Strategy 1 The original cloning strategy (Cloning Strategy 1) can be seen
in flowsheet A1 in appendix A. The original strategy include isolating the three
components: the EGF-R cDNA, the complete 3* UTR, and an expression vector plasmid.
Each piece o f DNA was cut with restriction enzymes that produced complementary ends.
These ends were then to be ligated. Each component had its own unique considerations to
complete the clone.
EGF-R. The EGF-R cDNA is present in the BSEGF-R vector. The DNA is
digested with restriction enzymes Sac2 and X h o l. This cuts out the EGF-R cDNA (with
150 bp o f 3* UTR). Sac2 is at the 5’ end, while X hol is at the 3* end. The length o f the
EGF-R cDNA is approximately 4 kilobases (kb) long. Within this 150 bp o f 3’ UTR is the
Acll restriction site. EGF-R cDNA is isolated, and ready for ligation with the CMV
vector, and 3’ UTR gene.
CMV (pcDNA31 Vector. For ligation, both the CMV vector and EGF-R cDNA
must have identical restriction sites (two o f them). Both pieces o f DNA had X hol sites,
but only EGF-R cDNA has a Sac2 site. It was therefore necessary to produce a Sac2 site
in the CMV vector. A Bahml site was transformed into a Sac2 site. This was done by
digesting the pcDNA3 at the Bahml site. This produced cuts with sticky ends. The ends
were blunt ended, and a Sac2 linker inserted. The vector then had a Sac2 and X hol sites.
The CMV DNA was double digested with Sac2 and X h o l.
The EGF-R cDNA (insert) was ligated into the CMV vector. This hybrid
contained the 150 base pair o f 3’ UTR, and was called CM V-EGF-R
3* U TR. The entire 3* UTR is stored in the pcUTR vector. The 3’ UTR contains
an A cll site at the 5s end, but no X hol site. A Sac2 site at the 3’ end o f the UTR was
then transformed into a X hol site. This was accomplished by digesting the plasmid with
Sac2, blunt ending the DNA, and ligating in a X hol linker. The entire 3’ UTR is then
digested out with Acll and X h o l. This linear insert was then ready to be ligated into the
CMV-EGF-R.
Prior to ligation o f the 3’ UTR insert into the CMV-EGF-R vector, a problem was
discovered. The original strategy required that the CMV-EGF-R be digested with Acll
and X hol. The entire 3’ UTR, digested with Acll and X hol, was then to be ligated into
the vector. It was discovered that an Acll site was present in the amp gene o f the CMVEGF-R. Digesting the CMV-EGF-R with Acll (to ligate in the 3* UTR) would destroy

the amp gene. There would be no way to select for the plasmid. This problem resulted in
cloning strategy 2.
Cloning Strategy 2 The flow sheet for Cloning Strategy 2 can be seen in
flowsheet A2 in appendix A. The process in this strategy is to clone the entire 3* UTR
into the CMV-EGF-R plasmid via different restriction sites. The EGF-R is digested with
Seal and X hol. The 3 ’ UTR is digested with the same enzymes, and the CMV-EGF-R
and entire 3* UTR are cloned together.
BSEGF-R. The EGF-R cDNA was removed from the BSEGF-R plasmid by
digestion with Sac2 and X h o l. The EGF-R cDNA was cloned into the modified pcDNA3
to form pcDNA3 (CMV-EGF-R). The EGF-R cDNA contains a Seal site approximately
1.7 kb upstream from the 3’ X hol end. The fragment is as follows:
Fig. 4 EGF-R Fragment (4 kb)
/----------- 1.7 k b ----- — /
A— 1.5 k b -■—/
— 3’
5’ ------ --------/--------------------------------------------------- /-------- -/Sac2
Start
/1 5 0 b p /
X hol
Stop Seal
3818 3970
This fragment was to be cut at Seal and X hol, and the 3’ U TR cloned in.
pcDNA3. The plan was to abolish the Seal site in the amp gene. This was to be
accomplished by digesting the pcDNA3 with S e a l. This would have produced a blunt end
cut to which a Clal linker could have been inserted. Once the site was changed, the
EGF-R cDNA was cloned into it.
3* UTR. The entire 3* UTR was present in the pGemZfS plasmid. The entire 3’
UTR was cut out with Seal and X hol. The plan was to isolated the entire 3 ’ UTR, and
clone it into the CMV-EGF-R plasmid.
After further analysis, a potential problem was noted. Replacing the Seal site in
the amp gene with a Clal linker would lengthen the amp gene. The Seal site was in the
middle o f the amp gene, the probable coding region. Adding bases at this point may have
resulted in a mutation that ceased gene function. To overcome this problem, a modified
version o f this cloning strategy was developed.
Cloning Strategy 3 The flowsheet for this strategy is A3 in appendix A. The idea
behind this strategy is to partially digest the CMV-EGF-R vector with S e a l. The partial
digestion would result in some o f the DNA being cut in the amp gene, and other DNA to
be cut in the EGF-R region. The X hol region would then be cut, and the 3’ UTR cloned
in. The DNA would be transformed into competent cells, and plated on amp plates.
Those clones with the intact amp gene would survive.
Restriction enzymes, depending on the type and how fresh the enzyme is, have
different rates o f effectiveness. For the partial digest to work, the rate needed to be
optimized, so both sites would not be cut. A series o f experiments were run to determine
the optimal time to perform the partial digest. Five digests were set up. Each digest
contained a fixed amount o f both the CMV-EGF-R plasmid DNA, and Seal enzyme. The
digests were incubated in a 37°C water bath for 2 ,4 , 6, 8, and 16 minutes. The reaction

was stopped by adding 1 pi o f 0.5M EDTA. The samples were run on an agarose gel to
check for double cuts. Photograph #1 in appendix B shows the results o f the digest. All
the samples resulted in double cuts. Seal turned out to be an extremely efficient enzyme.
The experiment was repeated with a 1:10 dilution o f the Seal enzyme. Photo #2 in
appendix B shows that the 2 minute digest resulted in the partial digest. A large (50 pg)
digest was performed. The digest was run out in a large well, removed, and gene cleaned
(photo #3). The partially digested CMV-EGF-R was digested with X hol, and gene
cleaned. This was to produce the CMV-EGF-R vector with a Seal and X hol sticky end.
The 3 ’ UTR was to be double digested with Seal and X h o l. A problem was
discovered in that the 3’ U TR was incorrect (no X hol site). The correct UTR (with the
X hol site) was grown up, isolated, and double digested with Seal and X hol. The DNA
was gene cleaned and treated with LiCl (for RNA). When the DNA concentration was
measured using a spectrophotometer, the concentration was very low compared to the
large pellet after isolation. The suspected problem was the LiCl used. The approximate
concentration was determined by running a small sample out on a gel. The 3’ UTR
concentration was less than originally expected, therefore an additional 20 pg o f 3* UTR
was double digested (Scal/X hol).
A sample o f insert (2 pi), and plasmid (1 pi) were run out side by side on an
agarose gel. Both bands had approximately the same intensity. Due to the size difference,
(at equal intensity) there is approximately 3 times more insert (1.5 kb 3* UTR) than vector
(9 kb plasmid & EGF-R cDNA). When ligating pieces o f DNA with 2 sticky ends, it is
optimal to have 4-5 times more inset than vector. Excess insert is desired because o f the
possibility o f religation o f the plasmid. A large amount o f entire 3* UTR increases the
chances o f the 3* UTR being inserted into the vector. A ligation o f the CMV-EGF-R and
entire 3’ UTR (with 4-5 time greater concentration o f insert) was performed. The DNA
was transformed into competent cells, and plated on amp plates. N o vector/insert colonies
grew. Growth on the negative control plate was noted. A small sample o f the vector and
insert were run on a gel to verify that the DNA was correct (photo #4). Each DNA
looked correct, and the experiment was repeated with the same DNA concentrations.
Samples o f competent cells, LB growth medium, and TSB/Glucose were plated on amp
plates as controls. This was to check for contamination at various sources. All three
control samples grew. This lead to the suspicion that the amp plates did not contain
ampicillian. New amp plates were made, and a sample o f competent cells were plated.
The competent cells did not grow (ampicillian was present in the plates), and the new amp
plates were used.
A new ligation was performed, colonies were isolated, grown to 2 ml volume, and
DNA isolated. The hybrid DNA was digested with X h o l. The DNA did not cut at the
correct lengths, the bands were all too small.
The hybrid DNA was digested with: (1) X hol, (2) Seal, and (3) Scal/X hol
(photo #5). The double digest produced two bands (should be three), and the Seal digest
produced 1 band (should be two). This suggested that one o f the two Seal sites is either:
(1) not there, or (2) not cutting.
In an attempt to verify that the hybrid DNA had the entire 3’ UTR insert, the
hybrid DNA was digested with E coR l, X hol, and Seal. The EcoR l enzyme was used

because it is present in the 3’ UTR, and is not present in the plasmid. The results (photo
#6) suggested that the Seal site may have been missing.
At this point, the orientation o f the 3* UTR was also in question. If the 3* UTR
was in anti-sense (3* to 5’) to the CMV-EGF-R, then the digested DNA bands would be
different sizes than expected. To check the direction o f the 3* UTR, a digest with Aval
(5* end) and Sacl (3* end) was performed. This digest should have produced a 1.5 kb
band. The results suggested that the 3’ UTR was in antisense to the CM V-EGF-R
To verify the orientation, the DNA was sequenced. The 3* UTR was found to be
in the correct orientation. The results that were obtained were inconsistent with the
sequencing. How/why this occurred was unknown. At this point, this cloning strategy
was discontinued, and a new cloning strategy developed.
Cloning Strategy 4 The flowsheet for this strategy is A4 in appendix A. This
strategy was to produce the correct entire 3’ UTR by polymerase chain reaction (PCR).
This ensured that the insert was correct. The PCR insert was ligated into a pGem5 T
plasmid (appendix C). The vector contained a lac Z gene. This gene was cut, and has
overhanging thymine bases. These thymine bases are put on for ligation to the adenine
bases put on the PCR product. If an insert were ligated into the gene the colony would be
white. If no insert was put in, the plasmid would self-ligate, and the intact lac Z gene
would produce a blue colony. This blue-white selection made selecting for the colonies
with inserts easier. The ligation was very inefficient. Several ligations were attempted,
and none o f the colonies contained the insert. This process was continued, and a second
strategy started.
The second strategy was to cut the pGem3Zf plasmid with B am H l. This would
produce a blunt end cut. A sample o f 3’ UTR was blunt ended. The two pieces o f DNA
were to be ligated together. This strategy was put on hold when a colony o f pGem5
plasmid was found to possibly contain the 3’ UTR. This is the point where the clone is
currently at.
Conclusions
This cloning procedure turned out to be much more difficult, and time consuming
than originally expected. The procedure could have been more efficient with less
laboratory mistakes. These mistakes resulted in procedures being repeated. Some
problems could not have been avoided. For example, optimal concentrations o f DNA
needed to be determined for ligations. A Promega manual’s instructions did not produce
good results. The partial digest o f Seal also took time to find the optimal digestion
period. These were time consuming laboratory steps that could not be controlled.
Other factors, such as the disappearing Seal site, could not be controlled. These
factors resulted in wasted time because other factors were considered in error. When an
enzyme did not cut, the enzyme was used to digest a different plasmid to ensure the
enzyme was working. Various steps such as this slowed the process down.
The clone is not finished at this time, but appears close to completion. It would
greatly benefit future cloners to have each piece o f DNA sequenced before ligation. It
would also benefit future experimenters to know all the restriction sites in selective genes
(i.e. amp gene) before attempting ligations. These steps will save the experimenter time
and frustration.

A ppendix A - C loning Strategy Flowsheets
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